Literature DB >> 10553681

Theiler's murine encephalomyelitis virus (TMEV) subgroup strain-specific infection in neural and non-neural cell lines.

M Obuchi1, J Yamamoto, N Uddin, T Odagiri, H Iizuka, Y Ohara.   

Abstract

GDVII subgroup strains of Theiler's murine encephalomyelitis virus (TMEV) are highly virulent and produce acute polioencephalomyelitis in mice. Neither viral persistence nor demyelination is demonstrated in the few surviving mice. In contrast, DA subgroup strains are less virulent and establish a persistent central nervous system infection which results in demyelinating disease. We previously reported a subgroup-specific infection in a macrophage-like cell line, J774-1 cells; i.e., GDVII strain does not replicate in J774-1 cells, whereas the DA strain actively replicates in these cells. In addition, this subgroup-specific virus growth is shown to be related to the presence of L* protein, a 17 kDa protein translated out-of-frame of the viral polyprotein from an AUG located 13 nucleotides downstream from the polyprotein's AUG. The present paper demonstrated that this subgroup-specific infection is observed in murine monocyte/macrophage lineage cell lines, but not in other murine cell lines including neural cells. An RNase protection assay also suggested that L* protein-related virus growth is regulated at the step of viral RNA replication. As macrophages are reported to be the major cell harboring virus during the chronic demyelinating stage, the activity of L* protein with respect to virus growth in macrophages may be a key factor in clarifying the mechanism(s) of TMEV persistence, which is probably a trigger to spinal cord demyelination.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10553681     DOI: 10.1111/j.1348-0421.1999.tb01223.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  8 in total

1.  L* protein of Theiler's murine encephalomyelitis virus is required for virus growth in a murine macrophage-like cell line.

Authors:  M Obuchi; J Yamamoto; T Odagiri; M N Uddin; H Iizuka; Y Ohara
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Influence of the Theiler's virus L* protein on macrophage infection, viral persistence, and neurovirulence.

Authors:  O van Eyll; T Michiels
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

3.  Cytokine/chemokine profile in J774 macrophage cells persistently infected with DA strain of Theiler's murine encephalomyelitis virus (TMEV).

Authors:  Toshiki Himeda; Takako Okuwa; Yasushi Muraki; Yoshiro Ohara
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

4.  Theiler's virus strain-dependent induction of innate immune responses in RAW264.7 macrophages and its influence on viral clearance versus viral persistence.

Authors:  Stephane Steurbaut; Bart Rombaut; Raf Vrijsen
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

5.  Evasion of antiviral innate immunity by Theiler's virus L* protein through direct inhibition of RNase L.

Authors:  Frédéric Sorgeloos; Babal Kant Jha; Robert H Silverman; Thomas Michiels
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

6.  Leader (L) and L* proteins of Theiler's murine encephalomyelitis virus (TMEV) and their regulation of the virus' biological activities.

Authors:  Masumi Takano-Maruyama; Yoshiro Ohara; Kunihiko Asakura; Takako Okuwa
Journal:  J Neuroinflammation       Date:  2006-08-16       Impact factor: 8.322

7.  Modulation of viral replication in macrophages persistently infected with the DA strain of Theiler's murine encephalomyelitis virus.

Authors:  Stephane Steurbaut; Ellen Merckx; Bart Rombaut; Raf Vrijsen
Journal:  Virol J       Date:  2008-08-04       Impact factor: 4.099

8.  Transcriptome analysis following neurotropic virus infection reveals faulty innate immunity and delayed antigen presentation in mice susceptible to virus-induced demyelination.

Authors:  Malgorzata Ciurkiewicz; Stefan Floess; Michael Beckstette; Maren Kummerfeld; Wolfgang Baumgärtner; Jochen Huehn; Andreas Beineke
Journal:  Brain Pathol       Date:  2021-07-06       Impact factor: 6.508

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.